A Joplin dentist who was charged with trafficking fentanyl while awaiting trial in a fatal hit-and-run could lose his license ...
ADIA Nutrition Inc. (OTC Pink: ADIA), a trailblazer in healthcare innovation, proudly announces a major milestone for its new ...
Injectable drugs like Ozempic and Wegovy may be new to most of the world, but the science behind them are familiar to those in the health field.
The U.S. Food and Drug Administration (FDA) has accepted Genentech’s Supplemental Biologics License Application (sBLA) for ...
In the SWIFT and ANCHOR trials, depemokimab demonstrated statistically significant reductions in nasal polyp size, ...
Zacks Investment Research on MSN1d
Ionis Out-Licenses Rights for Rare Blood Cancer Drug to OnoIonis Pharmaceuticals IONS signed a license agreement with Japan-based Ono Pharmaceutical. Per the terms, Ono has acquired ...
Al Jazeera on MSN5h
Families of Duterte’s drug war victims grieve, seek justice in PhilippinesFamilies of victims of the deadly police campaign have called on the ICC to go after other officials alongside Duterte.
Submission is supported by positive results from the Phase III REGENCY trial, which demonstrated that nearly half of patients ...
The genuineness of the drug licenses can be verified through the Third Party Verification system, which is available on the DCA website, the advisory said ...
announced today that the U.S. Food and Drug Administration (FDA) has accepted the company’s supplemental Biologics License Application (sBLA) for Gazyva ® (obinutuzumab) for the treatment of ...
The obesity medicine field has gained a new entrant, with AbbVie licensing an experimental drug from a Danish company.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback